Phathom Pharmaceuticals Set to Share Q1 2025 Insights Soon

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

CRESYN: Urban Elegance Hits Long Island City Who doesn't want to peek under the hood when a flashy new ride rolls into town? CRESYN's newly unveiled model residence in Long Island City is just that—an invitation to get up close and personal with what modern urban living can be. Forget the blueprints and glossy renderings. This place is the real deal, giving you that...

Clark Pacific's Bold Expansion You've got to admire the guts it takes to break new ground, both literally and figuratively. That's exactly what Clark Pacific is doing by launching a spanking new facility in Coolidge, Arizona. It ain't just any plant, either. We're talking about a colossal 110-acre site that'll eventually boost the company's production capacity threefold....

Rethinking Long-Length Imaging with Carestream The medical imaging sector just got a shot in the arm with Carestream Healthcare International's latest leap in technology. The DRX?LC Detector is not just a fancy update — it's a full-on revolution for long?length imaging. Forget the old days of piecing multiple exposures together, because this innovation simplifies...

Terrabis Unveils a Speedier Cannabis Experience What do you do when the world is demanding faster service? You innovate. That’s precisely what Terrabis has done by unveiling Illinois' first dual-window drive-thru dispensary in Grayville. Situated just off I-64, this facility isn't just offering a new way of doing things; it's setting the stage for what might very well...

DELIVAN Charging Forward with All-Electric Vans Mark the calendar—September 4, 2026, marked a big day for DELIVAN. The company's foray into the European market is getting serious, splashed across IAA Transportation in all its glory. Unveiling two fresh all-electric production vans, DELIVAN's not just tiptoeing onto the scene; it's diving headfirst into Europe's buzzing...

Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Unpacking Tetragon’s $50 Million Dutch Auction Move If you comb through the smoke-filled corridors of finance, you'll find the name Tetragon Financial Group pacing the latest tender offer rounds. They danced their way through a $50 million 'modified Dutch auction,' snapping up non-voting shares with a kind of ruthless efficiency that only seasoned market players can...

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Amalgamated Financial Corp. Declares Regular Quarterly Dividend Amalgamated Financial Corp., known for its commitment to financial excellence, has recently made an important announcement regarding its dividend policy. The Board of Directors has decided to declare a regular dividend of $0.14 per share for its common stockholders. This payment is a gesture of appreciation...

Insights into KBRA's Retail Sales Research KBRA has recently released significant research focusing on retail sales trends for August. Their findings reveal a small increase in retail sales, but they also indicate a clear decline in consumer resilience. This study comes at a time when inflation rates are dropping and the job market, while still strong, is starting to show...

Biogen's Current Market Position and Recent Developments Biogen Inc. (NASDAQ: BIIB), a prominent player in the biotechnology sector with a focus on neurological treatments, is navigating a pivotal moment. The company is poised to launch its much-anticipated Alzheimer's drug, Leqembi, while addressing recent challenges within its pipeline. This analysis delves into...

Morgan Stanley revised its stance on Suzlon Energy (SUEL:IN) back in mid-2024, downgrading its rating from Overweight to Equalweight. This shift came alongside an increase in the price target from INR73.00 to INR88.00, suggesting a strategic pivot after a jaw-dropping 106% spike in the company’s share price over six months. Performance Breakdown: Is It Justified? Now,...

A Pivotal Move in Renewable Energy Investment Copenhagen Infrastructure Partners (CIP) isn’t just dabbling in Australia's energy sector—they're going full throttle with the acquisition of the Gawara Baya project. This hybrid onshore wind and battery energy storage system (BESS) is a serious chunk of infrastructure designed to shake up North Queensland's power...